These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25912125)

  • 1. Uninterrupted dabigatran versus warfarin in the treatment of intracardiac thrombus in patients with non-valvular atrial fibrillation.
    Hao L; Zhong JQ; Zhang W; Rong B; Xie F; Wang JT; Yue X; Zheng ZT; Zhu Q; Zhang Y
    Int J Cardiol; 2015; 190():63-6. PubMed ID: 25912125
    [No Abstract]   [Full Text] [Related]  

  • 2. Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study.
    Durães AR; de Souza Roriz P; de Almeida Nunes B; Albuquerque FP; de Bulhões FV; de Souza Fernandes AM; Aras R
    Drugs R D; 2016 Jun; 16(2):149-54. PubMed ID: 26892845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin.
    Watanabe T; Shinoda Y; Ikeoka K; Inui H; Fukuoka H; Sunaga A; Kanda T; Uematsu M; Hoshida S
    Heart Vessels; 2017 Mar; 32(3):326-332. PubMed ID: 27406344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dabigatran use in elderly patients with atrial fibrillation.
    Avgil-Tsadok M; Jackevicius CA; Essebag V; Eisenberg MJ; Rahme E; Behlouli H; Pilote L
    Thromb Haemost; 2016 Jan; 115(1):152-60. PubMed ID: 26354766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial.
    Essebag V; Proietti R; Birnie DH; Wang J; Douketis J; Coutu B; Parkash R; Lip GYH; Hohnloser SH; Moriarty A; Oldgren J; Connolly SJ; Ezekowitz M; Healey JS
    Europace; 2017 Oct; 19(10):1630-1636. PubMed ID: 28339794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post PCI in Patients With Atrial Fibrillation.
    Steg PG; Ducrocq G; Bhatt DL; Hohnloser SH; Nordaby M; Miede C; Lip GYH; Oldgren J; Ten Berg JM; Cannon CP
    J Am Coll Cardiol; 2020 Jan; 75(2):238-240. PubMed ID: 31948654
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study.
    Calkins H; Willems S; Verma A; Schilling R; Hohnloser SH; Okumura K; Nordaby M; Kleine E; Bis B; Gerstenfeld EP
    Europace; 2019 Jun; 21(6):879-885. PubMed ID: 30982849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracardiac Thrombus Following Rivaroxaban Treatment in a Patient with Atrial Fibrillation Associated with Rheumatic Heart Disease.
    Ohara H; Yamamoto S; Nagano K; Hashikawa K
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104325. PubMed ID: 31427189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulant therapy and thrombosis. A case of failure of therapy with vitamin K antagonists.
    Romano P; Messina F; Crosca S
    Int J Cardiol; 2016 Jan; 203():1158-9. PubMed ID: 26608008
    [No Abstract]   [Full Text] [Related]  

  • 10. Is Dabigatran As Effective As Warfarin on Cardiac Thrombus in a Patient With Atrial Fibrillation? A Challenging Question.
    Sunbul M; Cincin A; Mammadov C; Mutlu B
    Am J Ther; 2016; 23(3):e974-6. PubMed ID: 25415546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Images in cardiology: fresh thrombus formation in left atrial appendage after temporary suspension of warfarin treatment in a patient with mitral stenosis and atrial fibrillation.
    Lairikyengbam SK; Knight C; Deaner A
    Heart; 2008 Dec; 94(12):1593. PubMed ID: 19011138
    [No Abstract]   [Full Text] [Related]  

  • 12. Does dabigatran interfere with intraablation heparinization?
    Sairaku A; Nakano Y; Kihara Y
    Thromb Res; 2014 Sep; 134(3):742-3. PubMed ID: 25034323
    [No Abstract]   [Full Text] [Related]  

  • 13. Dabigatran Versus Warfarin in Atrial Fibrillation: Multicenter Experience in Turkey.
    Aslan O; Yaylali YT; Yildirim S; Yurtdas M; Senol H; Ugur-Yildiz M; Ozdemir M
    Clin Appl Thromb Hemost; 2016 Mar; 22(2):147-52. PubMed ID: 25115764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
    Abraham NS; Singh S; Alexander GC; Heien H; Haas LR; Crown W; Shah ND
    BMJ; 2015 Apr; 350():h1857. PubMed ID: 25910928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter ablation for atrial fibrillation on uninterrupted warfarin: can it be done without echo guidance?
    Page SP; Siddiqui MS; Finlay M; Hunter RJ; Abrams DJ; Dhinoja M; Earley MJ; Sporton SC; Schilling RJ
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):265-70. PubMed ID: 21040095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
    Douketis JD; Healey JS; Brueckmann M; Eikelboom JW; Ezekowitz MD; Fraessdorf M; Noack H; Oldgren J; Reilly P; Spyropoulos AC; Wallentin L; Connolly SJ
    Thromb Haemost; 2015 Mar; 113(3):625-32. PubMed ID: 25472710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [COMPARATIVE EFFECTIVENESS AND SAFETY OF NEW ORAL ANTICOAGULANTS AND WARFARIN IN PATIENTS WITH AGE-SPECIFIC NON-VALVULAR ATRIAL FIBRILLATION].
    Shevelev VI; Kanorsky SG
    Klin Med (Mosk); 2015; 93(7):30-6. PubMed ID: 26596056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time-A RE-LY trial analysis.
    Hijazi Z; Hohnloser SH; Oldgren J; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Reilly PA; Yusuf S; Wallentin L
    Am Heart J; 2018 Apr; 198():169-177. PubMed ID: 29653640
    [No Abstract]   [Full Text] [Related]  

  • 19. Management and outcomes of major bleeding during treatment with dabigatran or warfarin.
    Majeed A; Hwang HG; Connolly SJ; Eikelboom JW; Ezekowitz MD; Wallentin L; Brueckmann M; Fraessdorf M; Yusuf S; Schulman S
    Circulation; 2013 Nov; 128(21):2325-32. PubMed ID: 24081972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Percutaneous left atrial appendage closure after resolution of left atrial appendage thrombi with dabigatran].
    Kis Z; Földesi C; Pál M; Som Z; Csillik A; Abrahám P; Temesvári A; Fontos G; Szatmári A; Andréka P; Kardos A
    Orv Hetil; 2013 Feb; 154(7):262-5. PubMed ID: 23395790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.